BioXcel Therapeutics, Inc. (BTAIQ)
0.052
+0.01
(+15.56%)
USD |
OTCM |
Oct 02, 16:00
BioXcel Therapeutics Max Drawdown (5Y) : 99.99% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.99% |
| August 31, 2026 | 99.97% |
| July 31, 2026 | 99.89% |
| June 30, 2026 | 99.89% |
| May 31, 2026 | 99.89% |
| April 30, 2026 | 99.89% |
| March 31, 2026 | 99.89% |
| February 28, 2026 | 99.89% |
| January 31, 2026 | 99.89% |
| December 31, 2025 | 99.89% |
| November 30, 2025 | 99.89% |
| October 31, 2025 | 99.89% |
| September 30, 2025 | 99.89% |
| August 31, 2025 | 99.89% |
| July 31, 2025 | 99.89% |
| June 30, 2025 | 99.89% |
| May 31, 2025 | 99.89% |
| April 30, 2025 | 99.86% |
| March 31, 2025 | 99.83% |
| February 28, 2025 | 99.83% |
| January 31, 2025 | 99.51% |
| December 31, 2024 | 99.51% |
| November 30, 2024 | 99.37% |
| October 31, 2024 | 99.20% |
| September 30, 2024 | 99.19% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.06% |
| July 31, 2024 | 98.38% |
| June 30, 2024 | 98.24% |
| May 31, 2024 | 97.25% |
| April 30, 2024 | 96.98% |
| March 31, 2024 | 96.98% |
| February 29, 2024 | 96.98% |
| January 31, 2024 | 96.41% |
| December 31, 2023 | 96.41% |
| November 30, 2023 | 96.41% |
| October 31, 2023 | 96.41% |
| September 30, 2023 | 96.15% |
| August 31, 2023 | 94.15% |
| July 31, 2023 | 90.11% |
| June 30, 2023 | 90.11% |
| May 31, 2023 | 86.03% |
| April 30, 2023 | 86.03% |
| March 31, 2023 | 86.03% |
| February 28, 2023 | 86.03% |
| January 31, 2023 | 86.03% |
| December 31, 2022 | 86.03% |
| November 30, 2022 | 86.03% |
| October 31, 2022 | 86.03% |
| September 30, 2022 | 86.03% |
| August 31, 2022 | 86.03% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
| Curis, Inc. | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -91.03 |
| Beta (5Y) | 0.3155 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 125.1% |
| Historical Sharpe Ratio (5Y) | -0.7023 |
| Historical Sortino (5Y) | -1.356 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 53.46% |